Tolero Pharmaceuticals, Inc. (Tolero)

Oncology Corporate Profile

HQ Location

2975 Executive Parkway, Suite #320
Lehi, UT 84043

Company Description

Tolero is a biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat and cure cancer and other life-threatening diseases. Tolero has used its innovative drug development platform to create a diverse portfolio of drug candidates targeting several cancer-associated cellular pathways.¥_Tolero Pharmaceuticals is a privately held company founded in 2011 and headquartered in Salt Lake City, Utah.

Website: http://www.toleropharmaceuticals.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
alvocidibCDK inhibitorAcute Lymphocytic Leukemia (ALL)II
alvocidibCDK inhibitorAcute Myelogenous Leukemia (AML)Preclinical
alvocidibCDK inhibitorMyelodysplastic Syndrome (MDS)Preclinical
TP-0903AXL kinase inhibitorVarious cancer typesPreclinical
TP-1287CDK9 inhibitorVarious cancer typesPreclinical
TP-3645PIM kinase inhibitorVarious cancer typesPreclinical
TP-0184BMPR signaling inhibitorVarious cancer typesPreclinical

View additional information on product candidates here »

Pipeline image

Source


http://www.toleropharmaceuticals.com

Recent News Headlines

There are no news items to display